Top Markets
Coin of the day
Xeno Transplants Corporation Xeno Transplants Corporation

Xeno Transplants Corporation

XENO
Rank in Stocks #42146
Xeno Transplants Corporation functions as a biotechnology firm dedicated to... Xeno Transplants Corporation functions as a biotechnology firm dedicated to research and development. Leveraging a specific licensing agreement with Massachusetts General Hospital, the company aims to innovate, produce, commercialize, and implement products and methodologies for public application in the field of xenotransplantation. The primary objective of this xenotransplantation research is to alleviate the critical scarcity of human cells, tissues, and organs required for medical transplants. This is achieved by pioneering techniques that enable the transfer of biological components—such as cells, tissues, and organs—from non-human species, including pigs, into human recipients. Established in 2004, Xeno Transplants Corporation maintains its headquarters in Brookline, Massachusetts.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$4.04K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
CA
Trade Xeno Transplants Corporation (XENO)

Category

Stock split history for Xeno Transplants Corporation (XENO)
Xeno Transplants Corporation stock (symbol: XENO) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 13, 2026.
One XENO share bought prior to Aug 13, 2026 would equal to 0 XENO shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR